Five Within Our Reach science investigators provided overviews and updates of their RA research projects to the newly formed Within Our Reach advisory board at its inaugural meeting, held November 8, 2007.
Search results for: physical function
Take the Measure of Osteoarthritis
The WOMAC index standardized OA status measurement, as described by its creator
Meet the Lumbar Spinal Stenosis Challenge
Limited evidence and diagnostic options make this increasing condition difficult to treat
Letters to the Editor
Feedback from Our Readers
Target Remission
Strategies to identify and track remission in your RA patients
Reading Rheum
Handpicked Reviews of Contemporary Literature
Science from our Sisters
Recommended reading from A&R and AC&R

A New Treatment for Fibromyalgia?
The FDA has approved a new drug application for TNX-102 SL (Tonmya), a tablet with 2.8 mg of cyclobenzaprine HCl, after two clinical trials demonstrated the safety and effectiveness of the treatment in adults with fibromyalgia.

Guidelines for ILD in Systemic Autoimmune Rheumatic Disease
Over 50% of patients with systemic sclerosis (SSc) develop interstitial lung disease (ILD), and rheumatologists have long recognized this major cause of morbidity and mortality.1 Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, and director of the Toronto Scleroderma Program, notes that more recent studies have increased our awareness…

Case Report: Pulmonary Artery Stenosis Secondary to Granulomatosis with Polyangiitis
This report presents a rare case of bilateral pulmonary artery stenosis secondary to granulomatosis with polyangiitis, underscoring the importance of recognizing large-vessel involvement as a potential manifestation of AAV; it also includes a narrative review analyzing eight previously reported cases.
- « Previous Page
- 1
- …
- 24
- 25
- 26
- 27
- 28
- …
- 81
- Next Page »